The final MC2 Center Virtual Symposium, Tumor & Metastasis Microenvironment, will take place on Thursday, July 30th, from 9:00 – 11:30 AM PT / 12:00 – 2:30 PM ET.
This Symposium will feature a keynote address, “B7-H3 CAR T cells: from the 1st intracranial dose to a child with DIPG to iterative laboratory design” by Dr. Nick Vitanza, University of Washington, in partnership with the patient advocate Fallon Tobin.
We will also feature a scientific session with talks and a panel discussion:
- Forcing inflammation to induce mutations that initiate cancer and drive metastasis – Dr. Valerie Weaver (UCSF)
- Bioengineering technologies for cancer organoid models – Dr. Sarah Heilshorn (Stanford)
- When tumors move: spatial reprogramming in metastatic CRC – Chien-Wei (Evan) Peng (Li Ding Lab – WUSTL)
- Die and let live: How apoptotic cells enhance circulating tumor cell survival and metastasis – Andrew Oberst (University of Washington).
Who Can Attend? Everyone! Please share this with your respective centers and projects, as well as your cancer research colleagues.
